Arteris (AIP) director sells 11,841 shares at $14
Arteris, Inc. director Antonio J. Viana reported insider sales on 10/06/2025.
Rhea-AI Filing Summary
Arteris, Inc. director Antonio J. Viana reported insider sales on 10/06/2025. The filing shows a sale of 11,841 shares of common stock at a price of $14 and an additional disposal of 20,840 common shares. After these transactions the reporting person is listed as beneficially owning 184,620 shares indirectly through the Viana Family Trust. The sales were made under a pre-existing Rule 10b5-1 trading plan that the reporting person adopted on 06/10/2025, and the Form 4 was signed by an attorney-in-fact on 10/06/2025. The filing presents routine, planned insider disposals rather than unscheduled or ad-hoc trades.
Positive
- None.
Negative
- None.
Insights
TL;DR: Director executed planned sales under a 10b5-1 plan, reducing indirect holdings.
The reported transactions show a director disposed of 11,841 shares at $14 and an additional 20,840 shares, with indirect beneficial ownership remaining at 184,620 shares via the Viana Family Trust. The filing explicitly states the trades were made under a 10b5-1 trading plan adopted on 06/10/2025, which is commonly used to provide an affirmative defense to insider trading claims.
The key dependency is that the trades followed the written plan; there is no disclosure of any other contemporaneous material event in this filing. Monitor future periodic filings for any change in pace of disposals or a termination/amendment to the 10b5-1 plan within the next reporting cycle.
TL;DR: This Form 4 documents routine scheduled dispositions and shows remaining indirect holdings.
The Form 4 records two disposals and reports the ownership format as indirect through a family trust; the signature is by an attorney-in-fact, which is a standard administrative execution. The price per share for one reported sale is $14.
Risks are procedural: ensure subsequent Forms 4/5 reconcile total holdings and that disposals align with any future 10b5-1 notices; such reconciliation typically appears in the next quarterly filings or subsequent Form 4s.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 11,841 | $14.00 | $166K |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- F1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on June 10, 2025.
FAQ
What did Arteris director Antonio J. Viana report on Form 4 (AIP)?
Were the Arteris (AIP) sales made under a trading plan?
Who signed the Form 4 for the Arteris reporting person?
How is the remaining Arteris stock owned after the transactions?
Does this Form 4 disclose any new derivative holdings or exercises for AIP?
AI-generated analysis. How Rhea-AI works. Not financial advice.